Arthur C Butcher
CIK 1678249 · EVP& Grp Pres, MedSurg & APAC · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BSX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752
Holdings By Company
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| BSX | Direct | 56,887 | 73.8% | 2026-05-04 |
| By 401(k) | 20,228 | 26.2% | 2026-05-04 | |
| Total | 77,115 |
10b5-1 Trading Plans
3 plans · 1 in force| Company | Adopted | Sales Can Start | Ends | Plan Allows | Sold So Far | Status | Link |
|---|---|---|---|---|---|---|---|
| BSX Executive Vice President and Group President, MedSurg and Asia Pacific |
Aug 28, 2025 | Nov 26, 2025 | Feb 1, 2027 | 162,648 shares | None filed | Active | 10-Q |
| BSX Executive Vice President and Group President, MedSurg and Asia Pacific |
Aug 9, 2024 | Nov 7, 2024 | Jan 30, 2026 | 69,253 shares | 69,253 (100%) last filed Dec 2, 2025 |
Ended | 10-Q |
| BSX Executive Vice President and Group President, MedSurg and Asia Pacific |
Nov 22, 2023 | Feb 22, 2024 | Jan 31, 2025 | 148,943 shares | 51,368 (34%) last filed Nov 25, 2024 |
Ended | 10-K |
Recent Filings · Page 9 of 10
99 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-04 | BSX | Mixed | +808 | -$28.8K | EDGAR |
| 2019-02-26 | BSX | Mixed | +1,812 | -$65.4K | EDGAR |
| 2019-02-25 | BSX | Mixed | — | -$499.2K | EDGAR |
| 2019-02-22 | BSX | Grant (A) | — | $0 | EDGAR |
| 2019-02-19 | BSX | Mixed | +879 | -$38.6K | EDGAR |
| 2018-11-13 | BSX | Sell (S) | −4,000 | -$154.0K | EDGAR |
| 2018-06-04 | BSX | Mixed | +932 | -$25.4K | EDGAR |
| 2018-05-11 | BSX | Sell (S) | −7,500 | -$225.4K | EDGAR |
| 2018-03-01 | BSX | Mixed | +2,614 | -$62.6K | EDGAR |
| 2018-02-26 | BSX | Mixed | +1,204 | -$32.8K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).